首页> 外文期刊>Journal of cellular biochemistry. >MicroRNA-29b Inhibits Migration and Proliferation of Vascular Smooth Muscle Cells in Neointimal Formation
【24h】

MicroRNA-29b Inhibits Migration and Proliferation of Vascular Smooth Muscle Cells in Neointimal Formation

机译:MicroRNA-29b抑制新生内膜形成中血管平滑肌细胞的迁移和增殖

获取原文
获取原文并翻译 | 示例
           

摘要

The proliferation and migration of smooth muscle cells (SMCs) are considered to be key steps in the progression of atherosclerosis and restenosis. Certain stimuli, such as, interleukin-3 (IL-3) are known to stimulate proliferation and migration in vascular diseases. Meanwhile, microRNAs (miRs) have been revealed as critical modulators of various diseases in which miR-29b is known to regulate cell growth by targeting Mcl-1 and MMP2. However, roles of miR-29b in vascular smooth muscle cells remain almost unknown. We hypothesized that miR-29b may control the proliferation and migration processes induced by IL-3 stimulation by inhibiting its own specific targets in SMCs. MiR-29b significantly suppressed the proliferation and migration of SMCs through the inhibition of the signaling pathway related to Mcl-1 and MMP2. We also found that miR-29b expression levels significantly declined in balloon-injured rat carotid arteries and that the overexpression of miR-29b by local oligonucleotide delivery can inhibit neointimal formation. Consistent with the critical role of miR-29b in vitro, we observed down-regulated expression levels of Mcl-1 and MMP2 from the neointimal region. These results indicate that miR-29b suppressed the proliferation and migration of SMCs, possibly through the inhibition of Mcl-1 and MMP2, and suggest that miR-29b may serve as a useful therapeutic tool to treat cardiovascular diseases such as, atherosclerosis and restenosis. J. Cell. Biochem. 116: 598-608, 2015. (c) 2014 Wiley Periodicals, Inc.
机译:平滑肌细胞(SMC)的增殖和迁移被认为是动脉粥样硬化和再狭窄进展的关键步骤。已知某些刺激物,例如白介素3(IL-3)可刺激血管疾病中的增殖和迁移。同时,microRNA(miRs)已被揭示为多种疾病的关键调节剂,其中已知miR-29b通过靶向Mcl-1和MMP2来调节细胞生长。但是,miR-29b在血管平滑肌细胞中的作用仍然未知。我们假设miR-29b可能通过抑制SMC中自身的特异性靶标来控制IL-3刺激诱导的增殖和迁移过程。 MiR-29b通过抑制与Mcl-1和MMP2相关的信号通路,显着抑制SMC的增殖和迁移。我们还发现,miR-29b表达水平在球囊损伤的大鼠颈动脉中显着下降,并且局部寡核苷酸递送导致miR-29b的过表达可以抑制新内膜的形成。与miR-29b在体外的关键作用相一致,我们观察到了来自新内膜区域的Mcl-1和MMP2的表达下调。这些结果表明,miR-29b可能通过抑制Mcl-1和MMP2抑制了SMCs的增殖和迁移,并且表明miR-29b可以作为治疗心血管疾病(如动脉粥样硬化和再狭窄)的有用治疗工具。 J.细胞。生化。 116:598-608,2015。(c)2014 Wiley Periodicals,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号